Table 3.
Variable | OR (95% Cl)a | P-valueb |
---|---|---|
Quartile aflatoxin (pg/mg albumin) | 0.04 | |
Q2 vs. Q1 | 1.04 (0.53, 2.05) | 0.925 |
Q3 vs. Q1 | 1.92 (0.92,4.04) | 0.08 c |
Q4 vs. Q1 | 2.60(1.19, 5.69) | 0.02 |
Sex | 0.52 | |
Male | Reference | |
Female | 0.80 (0.40,1.58) | 0.52 |
Age (years) | 0.87 | |
18–29 | 1.15 (0.55, 2.40) | 0.71 |
30–39 | 0.97 (0.51,1.86) | 0.92 |
≥40 | Reference | |
CD4 count (cells/μl blood) | 0.00 | |
300–499 | Reference | |
≥500 | 0.34 (0.19, 0.61) | 0.00 |
Year of HIV diagnosis | 0.43 | |
2006–2007 | Reference | |
2008–2009 | 1.30 (0.68, 2.48) | 0.43 |
OR = odds ratio; Cl = confidence interval.
Bold P-values are significant at P<0.05.
Marginally significant.